Alamar Biosciences, Inc.
ALMR
$29.36
-$0.60-1.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Net Income | -13.20M | -21.33M | -7.02M | ||
| Total Depreciation and Amortization | 1.13M | 1.17M | 919.00K | ||
| Total Amortization of Deferred Charges | 70.00K | 67.00K | 44.00K | ||
| Total Other Non-Cash Items | 5.45M | 11.13M | 717.00K | ||
| Change in Net Operating Assets | -4.78M | -11.39M | -6.54M | ||
| Cash from Operations | -11.32M | -20.35M | -11.88M | ||
| Capital Expenditure | -3.64M | -600.00K | -753.00K | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -117.15M | -178.00K | 18.70M | ||
| Cash from Investing | -120.80M | -778.00K | 17.95M | ||
| Total Debt Issued | 0.00 | 56.50M | -- | ||
| Total Debt Repaid | -6.15M | -- | -- | ||
| Issuance of Common Stock | 205.77M | 1.80M | 164.00K | ||
| Repurchase of Common Stock | -- | -- | -- | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | 2.22M | -2.54M | -- | ||
| Cash from Financing | 201.84M | 55.76M | 164.00K | ||
| Foreign Exchange rate Adjustments | 7.00K | -52.00K | 336.00K | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 69.73M | 34.58M | 6.56M | ||